Preventive Drug List
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Patriotic Lollipops
Patriotic Lollipops Perfect for your July 4th celebrations! To make the centerpiece pictured, see instructions below recipe. Ingredients Hard Candy Recipe (3 batches-one for each color) 1 teaspoon LorAnn Super Strength Flavoring of choice (for each batch) (we used blueberry, raspberry and pina colada) 1/4 teaspoon White Liquid Food Coloring 1/8 teaspoon Sky Blue Gel Food Coloring 1/8 teaspoon Ruby Red Gel Food Coloring 2 Bright Star Lollipop sheet molds 2 Stars Lollipop sheet molds 1 Stars Pieces sheet mold Directions White Lollipops 1. Spray Bright Star and Stars Lollipop molds lightly with cooking spray and insert sucker sticks. 2. Follow directions for making hard candy, adding 1/4 teaspoon of white liquid food coloring when syrup mixture reaches 260°F. Do not stir; boiling action will incorporate color. Continue cooking as directed. 3. When boiling action ceases, stir in flavoring. Allow mixture to rest a few seconds until large bubbles are no longer visible. Pour candy syrup into prepared star molds first, then pour excess into the star pieces mold. 4. Allow candy to harden on the counter for 10 to 15 minutes. Remove from molds. For optimal storage, cover lollipops with sucker bags and secure with twist ties. Store piece candy in an airtight container. Do not refrigerate. Blue Lollipops Follow directions for making the white lollipops, substituting 1/8 teaspoon of the Sky Blue Gel food coloring for the White Liquid color. Share your creations with us on social media! #lorannoils @lorannoils Red Lollipops Follow directions for making the white lollipops, substituting 1/8 teaspoon of the Ruby Red Gel food coloring for the White Liquid color. -
NEISS Coding Manual January 2019
NEISS Coding Manual January 2019 NEISS – National Electronic Injury Surveillance System January 2019 Table of Contents Introduction .............................................................................................................................. 1 General Instructions ................................................................................................................ 1 General NEISS Reporting Rule................................................................................................ 2 Do Report ............................................................................................................................... 2 Definitions ........................................................................................................................... 2 Do Not Report ........................................................................................................................ 3 Specific Coding Instructions ................................................................................................... 4 Treatment Date ...................................................................................................................... 4 Case Number ......................................................................................................................... 5 Comments/Narrative ............................................................................................................... 5 Abbreviations ..................................................................................................................... -
Flamingo Ingredients Chocolate Cupcakes Topped with Frosting
VIRTUAL CHOCOLATE-COVERED WEEKEND Flamingo Ingredients Chocolate cupcakes topped with frosting. ● Chocolate cupcakes (1 box/batch) ● Vanilla frosting (1 container) ● Pink food coloring ● Mini marshmallows (1 10.5 oz bag) ● Chocolate chips or black cake writing gel ● Lollipop sticks or straws Preparation 1. Make a batch of your favorite cupcakes. Once cool, arrange them on a platter in the shape of a flamin- go. 2. Mix the pink food coloring with the frosting in a bowl using a hand mixer. 3. Scoop the pink frosting into a piping bag or ziplock Inspired by our mosaiculture flamingo: with a corner cut off. Gently squeeze the frosting onto the cupcakes using a swirling motion. 4. Place marshmallows, chocolate chips and black cake gel on the “head” to make a face (see photo). Place straws for legs. 5. Eat and enjoy! Tips You could make flamingo faces on each cupcake in- stead by adding chocolate chips and other decorations in a face shape. Or decorate your cupcake to look like a creature of your own imagining. Our favorite food coloring McCormick’s “Nature’s Inspi- Ready in 1 hour ration” because it is made from plants instead of syn- Serves 20 people thetic dyes and has a vibrant pink color called “berry”. 10 of Hearts Ingredients Brownies topped with frosting and candy. ● Brownie mix (1 box/batch) ● Vanilla frosting (1 container) ● Black or red cake writing gel ● Candy hearts ● Lollipop sticks Preparation 1. Make a batch of your favorite brownies in a square or rectangular pan. 2. Once cool, cut the brownies into rectangles and slide 2 lollipop sticks halfway into a short end. -
California Essential Drug List
California Essential Drug List The Essential Drug List (formulary) includes a list of drugs covered by Health Net. The drug list is updated at least monthly and is subject to change. All previous versions are no longer in effect. You can view the most current drug list by going to our website at www.healthnet.com. Refer to Evidence of Coverage or Certificate of Insurance for specific cost share information. For California Individual & Family Plans: Drug Lists Select Health Net Large Group – Formulary (pdf). For Small Business Group: Drug Lists Select Health Net Small Business Group – Formulary (pdf). NOTE: To search the drug list online, open the (pdf) document. Hold down the “Control” (Ctrl) and “F” keys. When the search box appears, type the name of your drug and press the “Enter” key. If you have questions or need more information call us toll free. California Individual & Family Plans (off-Exchange) If you have questions about your pharmacy coverage call Customer Service at 1-800-839-2172 California Individual & Family Plans (on-Exchange) If you have questions about your pharmacy coverage call Customer Service at 1-888-926-4988 Hours of Operation 8:00am – 7:00pm Monday through Friday 8:00am – 5:00pm Saturday Small Business Group If you have questions about your pharmacy coverage call Customer Service at 1-800-361-3366 Hours of Operation 8:00am – 6:00pm Monday through Friday Updated September 1, 2021 Health Net of California, Inc. and Health Net Life Insurance Company are subsidiaries of Health Net, LLC and Centene Corporation. Health Net is a registered service mark of Health Net, LLC Table of Contents What If I Have Questions Regarding My Pharmacy Benefit? ................................... -
Recommended Methods for the Identification and Analysis of Fentanyl and Its Analogues in Biological Specimens
Recommended methods for the Identification and Analysis of Fentanyl and its Analogues in Biological Specimens MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES Laboratory and Scientific Section UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna Recommended Methods for the Identification and Analysis of Fentanyl and its Analogues in Biological Specimens MANUAL FOR USE BY NATIONAL DRUG ANALYSIS LABORATORIES UNITED NATIONS Vienna, 2017 Note Operating and experimental conditions are reproduced from the original reference materials, including unpublished methods, validated and used in selected national laboratories as per the list of references. A number of alternative conditions and substitution of named commercial products may provide comparable results in many cases. However, any modification has to be validated before it is integrated into laboratory routines. ST/NAR/53 Original language: English © United Nations, November 2017. All rights reserved. The designations employed and the presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the United Nations concerning the legal status of any country, territory, city or area, or of its authorities, or concerning the delimitation of its frontiers or boundaries. Mention of names of firms and commercial products does not imply the endorse- ment of the United Nations. This publication has not been formally edited. Publishing production: English, Publishing and Library Section, United Nations Office at Vienna. Acknowledgements The Laboratory and Scientific Section of the UNODC (LSS, headed by Dr. Justice Tettey) wishes to express its appreciation and thanks to Dr. Barry Logan, Center for Forensic Science Research and Education, at the Fredric Rieders Family Founda- tion and NMS Labs, United States; Amanda L.A. -
2017 List of Rule Based Prescription Drugs
2017 List of Rule Based Prescription Drugs Rule Explanation of Rule Prior Authorization Certain medications require a prior authorization. The medications requiring prior authorization are listed below. Your physician will need to complete a prior authorization form to determine if the medication will be approved for your medical condition. Contact EnvisionRXOptions Customer Service Help Desk at 1-800-361-4542 to start the Prior Authorization process. Quantity Limit Quantity limits are clinically recommended limits put in place to help ensure safe utilization of medication. Certain medications are subject to a quantity limit. If you are taking one of the medications mandating a quantity limit and the amount you take does not exceed the limit, you do not need to do anything. If you are in need of a medication that requires a higher quantity than that which is listed, you will need to have your prescribing physician submit a letter of medical necessity explaining why it is medically necessary for you to be on the exact dosage and quantity. You or your prescribing physician can begin the letter of medical necessity process by contacting EnvisionRXOptions Helpdesk at 1-800-361-4542. New-to-Market Medications Any medication approved to enter the market will only be covered after a clinical review decision has been made by the Envision Pharmacy and Therapeutics Committee who reviews safety, efficacy and cost information to determine whether or not the medication will be covered. If you attempt to fill or claim a non-covered New-to-Market medication, the claim will reject due to the medications New- to-Market classification. -
VHA/Dod CLINICAL PRACTICE GUIDELINE for the MANAGEMENT of POSTOPERATIVE PAIN
VHA/DoD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF POSTOPERATIVE PAIN Veterans Health Administration Department of Defense Prepared by: THE MANAGEMENT OF POSTOPERATIVE PAIN Working Group with support from: The Office of Performance and Quality, VHA, Washington, DC & Quality Management Directorate, United States Army MEDCOM VERSION 1.2 JULY 2001/ UPDATE MAY 2002 VHA/DOD CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF POSTOPERATIVE PAIN TABLE OF CONTENTS Version 1.2 Version 1.2 VHA/DoD Clinical Practice Guideline for the Management of Postoperative Pain TABLE OF CONTENTS INTRODUCTION A. ALGORITHM & ANNOTATIONS • Preoperative Pain Management.....................................................................................................1 • Postoperative Pain Management ...................................................................................................2 B. PAIN ASSESSMENT C. SITE-SPECIFIC PAIN MANAGEMENT • Summary Table: Site-Specific Pain Management Interventions ................................................1 • Head and Neck Surgery..................................................................................................................3 - Ophthalmic Surgery - Craniotomies Surgery - Radical Neck Surgery - Oral-maxillofacial • Thorax (Non-cardiac) Surgery.......................................................................................................9 - Thoracotomy - Mastectomy - Thoracoscopy • Thorax (Cardiac) Surgery............................................................................................................16 -
Medi-Cal Formulary May 2020
Formulary Medi-Cal MAY 2020 The IEHP Medi-Cal Formulary is subject to change throughout the year. All previous versions of the formulary are no longer in effect once a new formulary is available. The IEHP Medi-Cal Formulary can be found at: www.iehp.org/en/members/medical Last Updated: 04/17/2020 Inland Empire Health Plan (IEHP) Medi-Cal Formulary Table of Contents A . Foreword ..................................................................................................................... 2 B. IEHP Member Services .............................................................................................. 2 C. How to Use the Formulary .......................................................................................... 2 D. Prescription Coverage ................................................................................................. 3 D1. Quantity Limits .................................................................................................... 3 D2. Step Therapy ........................................................................................................ 3 E. Filling a Prescription and IEHP’s Pharmacy Network ............................................... 4 F. Definitions ................................................................................................................... 4 G. List of Covered Drugs .............................................................................................. 10 H. Index ....................................................................................................................... -
Inhalation Drug Delivery Devices: Technology Update
Medical Devices: Evidence and Research Dovepress open access to scientific and medical research Open Access Full Text Article REVIEW Inhalation drug delivery devices: technology update Mariam Ibrahim Abstract: The pulmonary route of administration has proven to be effective in local and Rahul Verma systemic delivery of miscellaneous drugs and biopharmaceuticals to treat pulmonary and non- Lucila Garcia-Contreras pulmonary diseases. A successful pulmonary administration requires a harmonic interaction between the drug formulation, the inhaler device, and the patient. However, the biggest single Department of Pharmaceutical Sciences, College of Pharmacy, problem that accounts for the lack of desired effect or adverse outcomes is the incorrect use The University of Oklahoma Health of the device due to lack of training in how to use the device or how to coordinate actuation Sciences Center, Oklahoma City, and aerosol inhalation. This review summarizes the structural and mechanical features of OK, USA aerosol delivery devices with respect to mechanisms of aerosol generation, their use with different formulations, and their advantages and limitations. A technological update of the current state-of-the-art designs proposed to overcome current challenges of existing devices is also provided. Keywords: pulmonary delivery, asthma, nebulizers, metered dose inhaler, dry powder inhaler Introduction Inhalation therapy has been used for thousands of years, albeit in a different form and use. Inhalation therapy was practiced by ancient civilizations in Egypt, Greece, India, and People’s Republic of China as evidenced by different artifacts displayed in museums, that may be considered the first used inhalation devices.1,2 Currently, inhalation therapy is the best option for lung diseases like asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). -
Olodaterol Monograph
Olodaterol Monograph Olodaterol (Striverdi Respimat) National Drug Monograph VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives The purpose of VA PBM Services drug monographs is to provide a comprehensive drug review for making formulary decisions. Updates will be made when new clinical data warrant additional formulary discussion. Documents will be placed in the Archive section when the information is deemed to be no longer current. FDA Approval Information Description/Mechan Olodaterol is a long-acting beta2-adrenergic agonist (LABA). Binding to and activating ism of Action beta2-adrenoceptors in the airways results in stimulation of intracellular adenyl cyclase, an enzyme that mediates the synthesis of cyclic-3’, 5’ adenosine monophosphate (cAMP). Elevated levels of cAMP induce bronchodilation by relaxation of airway smooth muscle cells. Indication(s) Under Long-term once daily maintenance bronchodilator treatment of airflow obstruction in Review patients with COPD including chronic bronchitis and/or emphysema Dosage Form(s) Inhalation spray for oral inhalation via Respimat (a soft-mist inhaler) Under Review The soft-mist inhalers (SMI) provide multi-dose medication using liquid formulations similar to that used in nebulizers and are propellant-free. Presently, Respimat is the only SMI commercially available for clinical use. The soft mist is released at a slower velocity and has more prolonged spray duration than the mist produced from pressurized metered dose inhalers (pMDIs). Pressurized MDIs require coordination of actuation with inhalation which may be difficult for some patients partly due to the rapid speed at which the drug is delivered and the short duration of the mist. -
Brick 10006390: Chewing Gum
Brick 10006390: Chewing Gum Definition Includes any products that can be described/observed as a type of gum made of chicle, a natural latex product, or synthetic equivalents such as polyisobutylene. Includes Bubble gum, which is a type of chewing gum, designed to be inflated out of the mouth as a bubble. Excludes Non–Chewing Gums and Anti–smoking treatments, and products that claim to be primarily Health Care or specific purpose gums such as Oral Care related like whiting, teeth cleansing. Diabetic Claim (20000056) Attribute Definition Indicates, with reference to the product branding, labelling or packaging, whether the product makes a claim to be suitable for consumption by consumers who have diabetes. Attribute Values NO (30002960) UNIDENTIFIED (30002518) YES (30002654) Special Occasion Claim (20000165) Attribute Definition Indicates, with reference to the product branding, labelling or packaging, the descriptive term that is used by the product manufacturer to identify whether the product is intended to be consumed for a special occasion. Attribute Values NO (30002960) UNIDENTIFIED (30002518) YES (30002654) Sugar Level Claim (20000174) Attribute Definition Indicates, with reference to the product branding, labelling or packaging, the descriptive term that is used by the product manufacturer to describe the level of sugar that is contained within the product. Page 1 of 15 Attribute Values CONTAINS SUGAR LOW SUGAR (30001471) UNCLASSIFIED (30002515) (30000744) SUGAR FREE (30002356) UNIDENTIFIED (30002518) Type of Chewing Gum (20002894) Attribute Definition Indicates, with reference to the product branding, labelling or packaging the descriptive term that is used by the product manufacturer to identify a particular type or variety of chewing gum. -
Oral Transmucosal Delivery for Improved Drug Bioavailability And
alenc uiv e & eq B io io B a f v o a i l l a Journal of a Vangara and Samala, J Bioequiv Availab 2015, 7:1 b n r i l i u t y o DOI: 10.4172/jbb.10000e58 J ISSN: 0975-0851 Bioequivalence & Bioavailability EditorialResearch Article OpenOpen Access Access Oral Transmucosal Delivery for Improved Drug Bioavailability and Patient Compliance Kiran K Vangara1* and Sushma Samala2 1Research and Development, Insys Therapeutics Inc., Chandler, AZ, USA 2Texas A&M University-Kingsville, Kingsville, TX, USA Since last 15 years the number of 505(b)(2) filings with new ODTs has been approved for different indications. The ODT market dosage forms for existing drug molecules at United states Food and is expected to exceed $13 billion by 2015 [5]. FDA defines ODT as Drug Administration (USFDA) has been increased tremendously. “a solid dosage form which contains a medicinal substance or active This is because of the tremendous increase in the developmental cost ingredient which disintegrates rapidly within a matter of seconds when of new chemical entities (NCE) and increased concerns about patient placed upon a tongue”. Various techniques such as direct compression, preferences and market demands for the novel unconventional dosage wet granulation, spray-drying, freeze-drying and sublimation were forms. These new dosage forms are being developed with improved used to prepare ODTs. Novel advanced technologies like Orasolv®, safety and efficacy together with patient compliance using novel drug Durasolv®, Wowtab®, Flashtab®, Zydis®, Flashdose®, Oraquick®, Lyoc®, delivery technologies [1]. Oral transmucosal drug delivery is rapidly Advatab®, Frosta®, Quick-Disc® and Nanomelt® are introduced by growing as a viable alternative for conventional oral dosage forms pharmaceutical companies for the preparation of ODTs.